Oral phenylephrine has been a staple in many OTC medications, marketed for its decongestant properties. However, the FDA’s comprehensive review—which included decades-old data as well as more ...

FDA proposes removal of common decongestant The API failed to deliver the resource. The FDA is moving to pull a decongestant from store shelves.

The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.

The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants.

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an ...

The Food and Drug Administration (FDA) is proposing to remove from the market a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work. The move brings FDA ...

The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine.

The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove such drugs from the market, it stated.

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed ...

At this point, the FDA's move remains a proposal only; the agency will accept comments on it until May 7, after which time the agency may move to a final order to remove phenylephrine from store ...